- Cancer Biology & Biomarkers
- Chromatography & Mass Spectrometry
- Contract Research, Clinical Trials and Outsourcing
- Drug Discovery
- Drug Targets
- Flow Cytometry
- Informatics & Lab Automation
- Ingredients, Excipients and Dosages
- Microbiology & RMMs
- NIR, PAT & QbD
- Raman Spectroscopy
- Screening, Assays & High-Content Analysis
- Thermal Processing
- Events & Workshops
Lilly Diabetes launches Android version of Glucagon Mobile app
15 July 2015 • Author: Victoria White
Lilly Diabetes has released an Android version of its Glucagon Mobile application designed for caregivers and healthcare providers who support people with diabetes.
The App serves as a teaching tool and can help caregivers prepare for treatment with Lilly Glucagon for Injection (rDNA origin) during a severe low blood sugar episode.
Through an injection tutorial and emergency instructions, the App can help people practice the injection steps ahead of time, which may help them feel better prepared to assist. Other features of the App include a kit location log, so kits can be easily located during an emergency, and an expiration date log that sends a reminder when a kit is getting close to its expiration date, so a new kit can be obtained before this date.
Lilly’s Glucagon Mobile App can be downloaded for free from Google Play and iTunes
Glucagon is a treatment for insulin coma or insulin reaction resulting from severe low blood sugar. Glucagon should not be used if you have pheochromocytoma or if you are allergic to Glucagon.
The Lilly Glucagon Mobile App for Android mobile devices is available as a free download on Google Play TM. It has been available on the iTunes® store as a free download for Apple mobile devices since September 2012.
“Lilly Diabetes is committed to developing personalized solutions to help people with diabetes achieve their treatment goals and improve their outcomes—including the creation of innovative online tools that provide a range of support,” said Matt Caffrey, senior director, consumer marketing, Lilly Diabetes. “The new version of the Lilly Glucagon Mobile App leverages the power of Android mobile technology, helping us reach even more caregivers and providing another opportunity to support people living with type 1 diabetes.”
ABB Analytical Measurement ACD/Labs ADInstruments Ltd Advanced Analytical Technologies GmbH Analytik Jena AG Astell Scientific Ltd Bachem AG Bibby Scientific Limited Bio-Rad Laboratories BioNavis Ltd Biopharma Group Black Swan Analysis Limited Charles Ischi AG | Kraemer Elektronik Cherwell Laboratories CI Precision Cobalt Light Systems Coulter Partners CPC Biotech srl Dassault Systèmes BIOVIA DiscoverX Edinburgh Instruments Enterprise System Partners (ESP) EUROGENTEC F.P.S. Food and Pharma Systems Srl IDBS JEOL Europe L.B. Bohle Maschinen + Verfahren GmbH Lab M Ltd. LabWare Linkam Scientific Instruments Limited Molins Technologies Multicore Dynamics Ltd Nanosurf New England Biolabs, Inc. Panasonic Biomedical Sales Europe B.V. PerkinElmer Inc ReAgent Russell Finex Limited Source BioScience Takara Clontech Tornado Spectral Systems Tuttnauer Watson-Marlow Fluid Technology Group Wickham Laboratories Limited Xylem Analytics YMC Europe GmbH Yusen Logistics